NEW YORK, August 23, 2016 /PRNewswire/ --
The Information Technology Services space includes companies that provide software support services, computer systems design, and data processing facilities management. Key challenges that have been impacting the industry are macroeconomic conditions, increasing use of automation, and digital disruption. Stock-Callers.com takes a look at these equities and see where they stand in the market today: Computer Sciences Corp. (NYSE: CSC), 21Vianet Group Inc. (NASDAQ: VNET), CSRA Inc. (NYSE: CSRA), and IMS Health Holdings Inc. (NYSE: IMS). You can access of our complimentary research reports on these stocks now at:
At the close on Monday, shares in Tysons, Virginia headquartered Computer Sciences Corp. rose 1.61%, ending the day at $46.78. The stock recorded a trading volume of 1.29 million shares. The Company's shares have surged 34.01% in the previous three months and 44.12% since the start of this year. The stock is trading above its 200-day moving average by 31.50%. Moreover, shares of Computer Sciences, which together with its subsidiaries, provides information technology services and solutions primarily in North America, Europe, Asia, and Australia, have a Relative Strength Index (RSI) of 41.88.
On August 17th, 2016, CSC announced that nbAccelerator,® its new business and automated underwriting system, has been named the winner of an XCelent Customer Base award in Celent's recently published North American New Business and Underwriting Systems 2016, Life, Annuity, and Health ABCD Vendor View. Visit us today and download your complete report on CSC for free at:
Shares in Beijing, the People's Republic of China headquartered 21Vianet Group Inc. ended the day 4.56% lower at $8.59. A total volume of 3.01 million shares was traded. The stock is trading below its 50-day moving average by 15.44%. Furthermore, shares of 21Vianet Group, which provides carrier-neutral Internet data center services to Internet companies, government entities, blue-chip enterprises, and small-to mid-sized enterprises in the People's Republic of China, have an RSI of 32.69.
On August 16th, 2016, 21 Vianet Group announced that net revenues for Q2 2016 increased by 5.1% to RMB910.8 million (US$137.1 million) from RMB866.8 million in the comparative period in 2015, primarily driven by a year-over-year increase in IDC, Cloud and VPN revenues, and partially offset by the decline in MNS revenues. The company's net loss for Q2 2016 was RMB123.8 million (US$18.6 million) compared to a net loss of RMB141.8 million in the comparative period in 2015.
On August 17th, 2016, research firm JP Morgan downgraded the Company's stock rating from 'Neutral' to 'Underweight'. The research firm also revised downwards its previous target price from $21 to $5.60. The complimentary research report on VNET can be accessed at:
On Monday, shares in Falls Church, Virginia headquartered CSRA Inc. finished 0.31% lower at $25.42 with a total volume of 804,966 shares traded. The stock has advanced 2.64% over the previous three months. The Company's shares are trading above their 50-day moving average by 2.51%. Additionally, shares of CSRA Inc., which delivers a range of IT solutions and professional services to help its U.S. government customers modernize their legacy systems, protect their networks and assets, and improve the mission-critical functions for warfighters and citizens, have an RSI of 47.27.
On August 10th, 2016, CSRA reported that GAAP revenue for Q1 FY17 was $1.25 billion, up 31% compared to Q1 FY16 as a result of the merger with SRA International, Inc. The company's GAAP net income was $68 million, or $0.39 per share, which includes $16 million of amortization of SRA contract backlog and $13 million of other pre-tax merger and integration costs. Register for free on Stock-Callers.com and download the PDF research report on CSRA at:
IMS Health Holdings
Danbury, Connecticut headquartered IMS Health Holdings Inc.'s shares recorded a trading volume of 550,042 shares at the end of yesterday's session and closed the day at $29.60, gaining 2.17%. The stock has advanced 3.39% in the last one month, 17.13% in the previous three months, and 16.22% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 7.52% and 13.06%, respectively. Additionally, shares of IMS Health Holdings, which provides information and technology services to healthcare industry worldwide, have an RSI at 61.03.
On July 27th, 2016, the company reported that revenue for Q2 $802 million increased 8.1% on a reported basis and 8.4% on a constant currency basis, compared to Q2 2015. Q2 2016 net income was $24 million compared to $47 million in last year's second Q2, with the decline principally attributable to higher restructuring charges in 2016. Get free access to your research report on IMS at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA